drugset / Trial / NCT07308756

Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery

NCT07308756

Phase 4 Recruiting 316 enrolled Peking University First Hospital
RandomizedFactorialQuadruple-blindPrevention

Summary

For patients after surgery, quality of recovery has significant impacts on the prognosis, quality of life, and rational allocation of medical resources. Dexmedetomidine and esketamine have each been used during the perioperative period and improved postoperative analgesia and subjective sleep quality. This 2x2 factorial trial is designed to explore the effects of dexmedetomidine, esketamine, and their combination on the quality of recovery in patients recovering from surgery under general anesthesia.

Timeline

Start
2026-01-05
Primary completion
2027-03
Completion
2027-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Esketamine Other / unclassified 0.1 mg/kg

Indications

No indication recorded.